Bovine lactoferrin drives cell cycle arrest and alters the transcriptomic profile of NSCLC cells
Non-small cell lung cancer (NSCLC) accounts for approximately 90% of all lung cancer cases. NSCLC is less sensitive to conventional chemotherapeutic agents, and high mortality and recurrence rates have become the impetus to find alternative therapies.